Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 1 for:    PROPPR
Previous Study | Return to List | Next Study

Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR)

This study has been completed.
Sponsor:
Collaborators:
Resuscitation Outcomes Consortium
Defence Research and Development Canada
Information provided by (Responsible Party):
John Holcomb, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT01545232
First received: February 29, 2012
Last updated: December 19, 2013
Last verified: December 2013